Evolution of gut microbiota in psoriatic arthritis treated with IL-17 inhibitor revealed by metagenomics - 01/07/25
Highlights |
• | IL-17 inhibitor treatment alters the composition and function of gut microbiota in PsA patients. |
• | After treatment, there was an increase in the α-diversity of gut microbiota, expansion of the Phocaeicola genus, and upregulation of CAZy. |
• | Species within the Phocaeicola genus may be the critical bacteria driving the evolution of gut microbiota in PsA patients treated with IL-17 inhibitors. |
Abstract |
Objectives |
To explore the evolution of gut microbiota in taxonomy and function in PsA patients during IL-17i treatment.
Methods |
Twenty PsA patients treated with secukizumab were included. Fecal samples were collected before treatment (0 mo.), first month (1 mo.) and third month (3 mo.) after treatment, and a total of 60 samples were collected. Shotgun metagenomic sequencing was used to detect all fecal samples.
Results |
In the 1 mo. and 3 mo. after IL-17i treatment, the disease activity in PsA patients decreased significantly. Compared with 0 mo., α-diversity calculated by Shannon index and Pielou index increased significantly at 1 mo. and 3 mo. after treatment. Microbial genes encoding Carbohydrate-Active enZymes (CAZymes) tended to be upregulated after treatment. After treatment, Bacteroidota phylum expanded, especially the abundance of Phocaeicola genus increased gradually with the treatment time (P<0.05). The abundance of Phocaeicola genus was positively correlated with the α-diversity. The Polysaccharide Lyases and Carbohydrate Esterases in CAZymes were significantly positively correlated with most of species in Phocaeicola genus.
Conclusions |
Treatment with IL-17i induces gut microbiota evolution in PsA patients. The key features of this evolution include increased α-diversity, expansion of the Phocaeicola genus, and upregulation of CAZymes. Species within the Phocaeicola genus may be the critical bacteria driving this evolution.
Le texte complet de cet article est disponible en PDF.Keywords : Psoriasis, Arthritis, Gut microbiota, Interleukin 17, Carbohydrate-Active enZymes
Plan
Vol 92 - N° 4
Article 105868- juillet 2025 Retour au numéro
Article précédent
- Association between osteoporosis and periodontitis
- Françoise Tilotta, Marjolaine Gosset, Julia Herrou, Karine Briot, Christian Roux
- Time-course of tophus resolution on Dual-energy CT and ultrasound after 24 months of a treat-to-target strategy: Results from GOUT-DECTUS study
- Tristan Pascart, Pascal Richette, Valérie Bousson, Sébastien Ottaviani, Hang-Korng Ea, Frédéric Lioté, Augustin Latourte, Thomas Bardin, Jérémy Ora, Aurore Pacaud, Marie Vandecandelaere, Hélène Luraschi, Charlotte Jauffret, Victor Laurent, Mathilde Boissel, Laurène Norberciak, Julie Legrand, Guillaume Lefevre, Vincent Ducoulombier, Jean-François Budzik
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?